CCI approved Zurich Insurance's acquisition of a 70% stake in Kotak Mahindra General Insurance, alongside other transactions involving Interise Investment Managers Limited and Shadowfax Technologies Private Limited.

Australian energy majors Woodside and Santos have ceased discussions on an A$85.7bn ($55.9bn) merger, citing a lack of identified combination benefits and maintaining a disciplined approach to mergers and acquisitions.

SP Apparels Ltd (SPAL) acquires Young Brand Apparel Private Limited (YBAPL) for Rs 223 crore, enhancing product offerings and manufacturing capacity, targeting expansion in global markets.

In 2023, the biopharma industry witnessed a resurgence in mergers and acquisitions, with the top 10 deals totaling $115.8 billion, led by Pfizer's $43 billion merger with Seagen, indicating renewed confidence despite the absence of monumental transactions like Bristol Myers Squibb's acquisition of Celgene or AbbVie's takeover of Allergan, with notable focus on antibody-drug conjugates (ADCs) and neuroscience, including BMS' $14 billion bid for Karuna Therapeutics and AbbVie's $8.7 billion takeover of Cerevel Therapeutics.